GENEVA: The International Federation of Pharmaceutical Manufacturers and Associations expressed disappointment Wednesday at the United States' decision to support a global waiver on patent protections for Covid-19 vaccines.
"As we have consistently stated, a waiver is the simple but the wrong answer to what is a complex problem," the lobby group said in a statement, describing the US move as "disappointing".
Comments
Comments are closed.